Pharm
Daunorubicin
search
Daunorubicin
, Daunomycin, Cerubidine
See Also
Antibiotic Chemotherapy
Chemotherapy
Indications
As part of Combination Regimens
Acute Myelogenous Leukemia
(AML, adults)
Acute Lymphocytic Leukemia
(ALL, adults and children)
Mechanism
See
Antibiotic Chemotherapy
Daunorubicin is an anthracycline
Aminoglycoside
antineoplastic
Daunorubicin is isolated from the bacterium Streptomyces peucetius (or Streptomyces coeruleorubidus)
Daunorubicin interacts with DNA via topoisomerase
Similar clinical effects as with
Doxorubicin
(hydroxylated form of Daunorubicin)
Inhibits
DNA Replication
and repair
Inhibits RNA and
Protein
synthesis
Medications
Injection Solution: 5 mg/ml in 4 and 10 ml vials
Combination Agents
Daunorubicin AND
Cytarabine Liposomal
(Vyxeos)
Dosing
See other references for disease specific dosing protocols
Adjust dosing in renal
Impairment
and hepatic
Impairment
Adverse Effects
Cardiotoxicity (esp. Children)
Infusion Reaction
Myelosuppression
Urine Discoloration
(transient red coloration)
Safety
Avoid in
Lactation
Avoid in pregnancy (all trimesters)
Use reliable
Contraception
Daunorubicin crosses the placenta
Monitoring
Complete Blood Count
Cardiac Function
Renal Function
tests
Liver Function Test
s
Resources
Daunorubicin for Injection (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=227784a8-ce68-4dd4-8ac5-a65265969677
Type your search phrase here